Covered recipient · General Payments record
DEBBIE JOYCE WILLIAMS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,839.50
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $978.38 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $241.25 | 2 |
| Daiichi Sankyo Inc. | $228.11 | 2 |
| ABBVIE INC. | $172.30 | 6 |
| Gilead Sciences, Inc. | $118.03 | 1 |
| Exelixis Inc. | $76.15 | 1 |
| Stemline Therapeutics Inc. | $68.59 | 1 |
| Janssen Biotech, Inc. | $48.91 | 1 |
| Merck Sharp & Dohme Corporation | $25.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.40 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108337195 | CMS |
| ABBVIE INC. | $7.48 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108337197 | CMS |
| ABBVIE INC. | $10.08 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108337199 | CMS |
| ABBVIE INC. | $16.35 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108337201 | CMS |
| ABBVIE INC. | $5.99 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108337203 | CMS |
| ABBVIE INC. | $125.00 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108337205 | CMS |
| AstraZeneca Pharmaceuticals LP | $119.41 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104593176 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.84 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105712774 | CMS |
| Daiichi Sankyo Inc. | $117.44 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089493012 | CMS |
| Daiichi Sankyo Inc. | $110.67 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089493026 | CMS |
| Exelixis Inc. | $76.15 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138569525 | CMS |
| Gilead Sciences, Inc. | $118.03 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133710723 | CMS |
| Janssen Biotech, Inc. | $48.91 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078342257 | CMS |
| Merck Sharp & Dohme LLC | $25.04 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141794974 | CMS |
| Stemline Therapeutics Inc. | $68.59 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142967385 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.